Cargando…
Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy
Coronavirus disease 2019 (COVID-19), the seventh human coronavirus infectious disease, was first reported in Wuhan, China, in December 2019, followed by its rapid spread globally (251,059 deaths, on May 5, 2020, by Johns Hopkins University). An early clinical report showed that fever, cough, fatigue...
Autor principal: | Aoe, Tomohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366900/ https://www.ncbi.nlm.nih.gov/pubmed/32754041 http://dx.doi.org/10.3389/fphar.2020.01095 |
Ejemplares similares
-
Pharmacological Chaperones Attenuate the Development of Opioid Tolerance
por: Okuyama, Youta, et al.
Publicado: (2020) -
Therapeutic Potential of Luffa acutangula: A Review on Its Traditional Uses, Phytochemistry, Pharmacology and Toxicological Aspects
por: Shendge, Parshuram Nivrutti, et al.
Publicado: (2018) -
Potential therapeutic strategies for quercetin targeting critical pathological mechanisms associated with colon adenocarcinoma and COVID-19
por: Li, Xiushen, et al.
Publicado: (2022) -
One stone two birds: anti-inflammatory bronchodilators as a potential pharmacological strategy for COVID-19
por: Yu, Yuanyuan, et al.
Publicado: (2023) -
The therapeutic potential of antioxidants, ER chaperones, NO and H(2)S donors, and statins for treatment of preeclampsia
por: Cindrova-Davies, Tereza
Publicado: (2014)